Skip to main content

Advertisement

Log in

Peripheral T/Natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases

  • Review Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Malignant lymphoma of the female genital tract (FGT) is rare. In this study, 5 peripheral T/natural killer (NK)-cell lymphomas (PTCLs) involving the FGT are reported. They include 2 from the uterus and 1 each from ovary, uterus and ovary, and vagina, and were detected between 1996 and 2000. One of the 2 ovarian tumors was bilateral. In all cases, the FGT was the initial site of clinical presentation of disease. Age at presentation ranged from 21 to 52 years (median, 36 years). One case was stage I disease, 2 were stage II, and 2 were stage IV. All 5 tumors were positive for CD3ε, and 3 harbored the Epstein-Barr virus, although the detailed immunophenotypic profiles varied. Three were diagnosed as nasal type T/NK-cell lymphoma, 1 as anaplastic large-cell lymphoma (anaplastic lymphoma kinase [ALK]-positive), and 1 as unspecified PTCL of cytotoxic phenotype, according to the forthcoming World Health Organization classification. Four of 5 patients received laparotomy and chemotherapy. Four patients (in stages II and IV) died of disease within 16 months of the initial diagnosis, whereas only 1 patient (in stage I) is alive without disease at 39 months of follow-up. Our experience in this series provided clinically relevant information on diagnosis, treatment, and outcome for extremely rare tumors of the FGT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.Blood. 1994;84:1361–1392.

    CAS  PubMed  Google Scholar 

  2. Jaffe ES. Hematopathology: integration of morphologic features and biologic markers for diagnosis [review].Mod Pathol. 1999;12:109–115.

    CAS  PubMed  Google Scholar 

  3. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997.J Clin Oncol. 1999;17:3835–3849.

    CAS  PubMed  Google Scholar 

  4. Rosenberg SA, Diamond HD, Jaslowitz B, Carver LF. Lymphosarcoma: a review of 1269 cases.Medicine. 1961;40:31–84.

    Article  CAS  PubMed  Google Scholar 

  5. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphoma.Cancer. 1972;29:252–260.

    Article  CAS  PubMed  Google Scholar 

  6. Chorlton I, Karnei RF, King FM, et al. Primary malignant reticuloendothelial disease involving the vagina, cervix and corpus uteri.Obstet Gynecol. 1974;44:735–748.

    CAS  PubMed  Google Scholar 

  7. Chorlton I, Norris HJ, King FM. Malignant reticuloendothelial disease involving the ovary as a primary manifestation: a series of 19 lymphomas and 1 granulocytic sarcoma.Cancer. 1974;34:397–407.

    Article  CAS  PubMed  Google Scholar 

  8. Rotmensch J, Woodruff JD. Lymphoma of the ovary: report of twenty new cases and update of previous series.Am J Obstet Gynecol. 1982;143:870–875.

    CAS  PubMed  Google Scholar 

  9. Osborne BM, Robboy SJ. Lymphoma or leukemia presenting as ovarian tumor: an analysis of 42 cases.Cancer. 1983;52:1933–1943.

    Article  CAS  PubMed  Google Scholar 

  10. Harris NL. Scully RE. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina: a clinicopathologic analysis of 27 cases.Cancer. 1984;53:2530–2545.

    Article  CAS  PubMed  Google Scholar 

  11. Barzilay J, Rakowsky E, Rahima M, Yanai-Inbar I. Malignant lymphoma of the ovary: report of a case and review of the literature.Obstet Gynecol. 1984;64:93S-94S.

    CAS  PubMed  Google Scholar 

  12. Piura B, Bar-David J, Glezerman M, Zirkin HJ. Bilateral ovarian involvement as the only manifestation of malignant lymphoma.J Surg Oncol. 1986;33:126–128.

    Article  CAS  PubMed  Google Scholar 

  13. Linden MD, Tubbs RR, Fishleder AJ, Hart WR. Immunotypic and genotypic characterization of non-Hodgkin’s lymphomas of the ovary.Am J Clin Pathol. 1988;89:156–162.

    Google Scholar 

  14. Fox H, Langley FA, Govan AD, Hill AS, Bennett MH. Malignant lymphoma presenting as an ovarian tumor: a clinicopathological analysis of 34 cases.Br J Obstet Gynaecol. 1988;95:386–390.

    CAS  PubMed  Google Scholar 

  15. Yamane T, Kirimoto K, Fujita M, et al. Ovarian involvement as an initial manifestation of malignant lymphoma.Jpn J Clin Oncol. 1989;19:163–166.

    CAS  PubMed  Google Scholar 

  16. Lamoureux D, Daya D, Simon GT. Cell junctions in lymphomas: study of a primary ovarian T-cell lymphoma and review of fifty-six other cases of lymphoma.Ultrastruct Pathol. 1990;14:247–252.

    Article  CAS  PubMed  Google Scholar 

  17. Liang R, Chiu E, Loke SL. Non-Hodgkin’s lymphomas involving the female genital tract.Hematol Oncol. 1990;8:295–299.

    Article  CAS  PubMed  Google Scholar 

  18. Ferry JA, Young RH. Malignant lymphoma, pseudolymphoma, and hematopoietic disorders of the female genital tract.Pathol Annu. 1991;26:227–263.

    PubMed  Google Scholar 

  19. Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ. Malignant lymphoma involving the ovary: a clinicopathologic analysis of 39 cases.Am J Surg Pathol. 1993;17:154–170.

    Article  CAS  PubMed  Google Scholar 

  20. Chandy L, Kumar L, Dawar R. Non-Hodgkin’s lymphoma presenting as a primary lesion in uterine cervix: case report.J Obstet Gynaecol. 1998;24:183–187.

    CAS  Google Scholar 

  21. Amichetti M, Chiappe E, Mussari S, et al. Primary non-Hodgkin’s lymphoma of the female genital tract.Oncol Rep. 1999;6:651–654.

    CAS  PubMed  Google Scholar 

  22. Guarini A, Pavone V, Valentino T, et al. Primary non-Hodgkin’s lymphoma of the vagina.Leuk Lymphoma. 1999;35:619–622.

    Article  CAS  PubMed  Google Scholar 

  23. Vang R, Medeiros LJ, Silva EG, Gershenson DM, Deavers M. Non-Hodgkin’s lymphoma involving the vagina: a clinicopathologic analysis of 14 patients.Am J Surg Pathol. 2000;24:719–725.

    Article  CAS  PubMed  Google Scholar 

  24. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.J Histochem Cytochem. 1981;29:577–580.

    CAS  PubMed  Google Scholar 

  25. Brousset P, Butet V, Chittal S, Selves J, Delsol G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immuno-histochemical correlation with anti-latent membrane protein antibody.Lab Invest. 1992;67:457–464.

    CAS  PubMed  Google Scholar 

  26. Griffiths GM, Mueller C. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells.Immunol Today. 1991;12:415–419.

    Article  CAS  PubMed  Google Scholar 

  27. de Bruin PC, Kummer JA, van der Valk P, et al. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization.Blood. 1994;84:3785–3791.

    PubMed  Google Scholar 

  28. Arnulf B, Copie-Bergman C, Delfau-Laure MH, et al. T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization.Blood. 1998;91:1723–1731.

    CAS  PubMed  Google Scholar 

  29. Felgar RE, Macon WR, Kinney MC, Roberts S, Pasha T, Salhany KE. TIA-1 expression in lymphoid neoplasms: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.Am J Pathol. 1997;150:1893–1900.

    CAS  PubMed  Google Scholar 

  30. Kagami Y, Suzuki R, Taji H, et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.Am J Surg Pathol. 1999;23:1184–1200.

    Article  CAS  PubMed  Google Scholar 

  31. Ho FC, Choy D, Loke SI, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic study of 16 cases.Hum Pathol. 1990;21:1041–1050.

    Article  CAS  PubMed  Google Scholar 

  32. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma.Lancet. 1990;335:128–130.

    Article  CAS  PubMed  Google Scholar 

  33. Suzumiya J, Takeshita M, Kimura M, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas.Blood. 1994;83:2255–2260.

    CAS  PubMed  Google Scholar 

  34. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas: definitions, differential diagnosis, and epidemiology.Am J Surg Pathol. 1996;20:103–111.

    Article  CAS  PubMed  Google Scholar 

  35. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.Blood. 1997;89:4501–4513.

    CAS  PubMed  Google Scholar 

  36. Nakamura S, Katoh E, Koshikawa T, et al. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese.Pathol Int. 1997;47:38–53.

    Article  CAS  PubMed  Google Scholar 

  37. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract.Am J Surg Pathol. 1995;19:284–296.

    Article  CAS  PubMed  Google Scholar 

  38. Suzumiya J, Ohshima K, Takeshita M, et al. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene.Leuk Lymphoma. 1999;35:567–578.

    Article  CAS  PubMed  Google Scholar 

  39. Chan JK, Tsang WY, Lau WH, et al. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.Cancer. 1996;77:1198–1205.

    Article  CAS  PubMed  Google Scholar 

  40. Shiota M, Nakamura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ ALK: a distinct clinicopathologic entity.Blood. 1995;86:1954–1960.

    CAS  PubMed  Google Scholar 

  41. Nakamura S, Shiota M, Nakagawa A, et al. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.Am J Surg Pathol. 1997;21:1420–1432.

    Article  CAS  PubMed  Google Scholar 

  42. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.Blood. 1998;91:2076–2084.

    CAS  PubMed  Google Scholar 

  43. Meguerian-Bedoyan Z, Lamant L, Hopfner C, et al. Anaplastic large cell lymphoma of maternal origin involving the placenta: case report and literature survey.Am J Surg Pathol. 1997;21:1236–1241.

    Article  CAS  PubMed  Google Scholar 

  44. Rukavina D, Podack ER. Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant?Immunol Today. 2000;21:160–163.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shigeo Nakamura.

About this article

Cite this article

Nakamura, S., Kato, M., Ichimura, K. et al. Peripheral T/Natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases. Int J Hematol 73, 108–114 (2001). https://doi.org/10.1007/BF02981911

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02981911

Key words

Navigation